Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantation

Stem Cells and Development

Volumn 21, Issue 9, 2012, Pages 1409-1417

  Uhlin, Michael ^a,b   Sairafi, Darius ^a,b   Berglund, Sofia ^a,b   Thunberg, Sarah ^a,b   Gertow, Jens ^a,b   Ringden, Olle ^a,b   Uzunel, Mehmet ^a   Remberger, Mats ^a,b   Mattsson, Jonas ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLIXIMAB; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; RITUXIMAB; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR EXCISION CIRCLE; TACROLIMUS; THYMOCYTE ANTIBODY; TREOSULFAN; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CANCER SURVIVAL; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; ELECTROPHORESIS; EXTRACORPOREAL PHOTOPHORESIS; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL PARAMETERS; INFANT; LYMPHOMA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE; THYMUS; THYMUS RECONSTITUTION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HLA ANTIGENS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; RETROSPECTIVE STUDIES; THYMUS GLAND; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84862166124     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0310     Document Type: Article

References (48)

1. Rocha V, G Sanz, E Gluckman and EE Blood. (2004). Umbilical cord blood transplantation. Curr Opin Hematol 11:375-385. (Pubitemid 39491430)
2. Gluckman E, V Rocha and S Chevret. (2001). Results of unrelated umbilical cord blood hematopoietic stem cell transplant. Transfus Clin Biol 8:146-154. (Pubitemid 32672968)
3. Okas M, O Ringden, M Uhlin, M Uzunel, M Remberger and J Mattsson. (2008). Unrelated cord blood or mismatched unrelated volunteer donor transplants in patients who lack an HLA-identical donor. BoneMarrow Transplant 41:S195-S196.
4. Grewal SS, JN Barker, SM Davies and JE Wagner. (2003). Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 101:4233-4244. (Pubitemid 36857783)
5. Wagner JE, NA Kernan, M Steinbuch, HE Broxmeyer and E Gluckman. (1995). Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and nonmalignant disease. Lancet 346:214-219.
6. Kohlikumar M, NT Shahidi, HE Broxmeyer, M Masterson, C Delaat, J Sambrano, C Morris, AD Auerbach and RE Harris. (1993). Hematopoietic stem progenitor-cell transplant in fanconi-anemia using hla-matched sibling umbilical-cord blood-cells. Br J Haematol 85:419-422.
7. Vilmer E, G Sterkers, C Rahimy, E Denamur, J Elion, A Broyart, B Lescoeur, JM Tiercy, J Gerota and P Blot. (1992). Hla-mismatched cord-blood transplantation in a patient with advanced leukemia. Transplantation 53:1155-1157.
8. Rocha V, M Labopin, G Sanz, W Arcese, R Schwerdtfeger, A Bosi, N Jacobsen, T Ruutu, M de Lima, et al.; ALWP Euro and MTGE Net. (2004). Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. New Engl J Med 351:2276-2285. (Pubitemid 39552743)
9. Laughlin MJ, M Eapen, P Rubinstein, JE Wagner, MJ Zhang, RE Champlin, C Stevens, JN Barker, RP Gale, et al. (2004). Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. New Engl J Med 351:2265-2275. (Pubitemid 39552742)
10. Barker JN, SM Davies, T DeFor, NKC Ramsay, DJ Weisdorf and JE Wagner. (2001). Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97:2957-2961.
11. Barker JN, DJ Weisdorf and JE Wagner. (2001). Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. New Engl J Med 344:1870-1871. (Pubitemid 32538709)
12. Barker JN, DJ Weisdorf, TE Defor and JE Wagner. (2004). Double unit myeloablative umbilical cord blood (UCB) transplantation in adults & adolescents: high incidence of engraftment and low transplant-related mortality. Blood 104:235a-236a.
13. Barker JN, DJ Weisdorf, TE DeFor, BR Blazar, PB McGlave, JS Miller, CM Verfaillie and JE Wagner. (2005). Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105:1343-1347. (Pubitemid 40170912)
14. Verneris MR, CG Brunstein, J Barker, ML MacMillan, T Defor, DH McKenna, MJ Burke, BR Blazar, JS Miller, et al. (2009). Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 114:4293-4299.
15. de Lima M, J McMannis, A Gee, K Komanduri, D Couriel, BS Andersson, C Hosing, I Khouri, R Jones, et al. (2008). Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant 41:771-778. (Pubitemid 351696340)
16. McNiece I, J Harrington, J Turney, J Kellner and EJ Shpall. (2004). Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 6:311-317. (Pubitemid 39214050)
17. Mackall CL, TJ Fry, C Bare, P Morgan, A Galbraith and RE Gress. (2001). IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97:1491-1497. (Pubitemid 32183777)
18. Fibbe WE, AJ Nauta and H Roelofs. (2007). Modulation of immune responses by mesenchymal stem cells. Ann NY Acad Sci 1106:272-278. (Pubitemid 47443061)
19. LeBlanc K, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, B Sundberg, ME Bernardo, et al. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579-1586. (Pubitemid 351626841)
20. Kebriaei P, L Isola, E Bahceci, K Holland, S Rowley, J McGuirk, M Devetten, J Jansen, R Herzig, et al. (2009). Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 15:804-811.
21. Ball LM, ME Bernardo, H Roelofs, A Lankester, A Cometa, RM Egeler, F Locatelli and WE Fibbe. (2007). Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110:2764-2767.
22. Ning H, F Yang, M Jiang, L Hu, K Feng, J Zhang, Z Yu, B Li, C Xu, et al. (2008). The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia 22:593-599. (Pubitemid 351386730)
23. Nademanee A, GM Schmidt, P Parker, AC Dagis, A Stein, DS Snyder, M O'Donnell, EP Smith, DE Stepan, et al. (1995). The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood 86:1228-1234.
24. Petersdorf EW, C Anasetti, PJ Martin and JA Hansen. (2003). Tissue typing in support of unrelated hematopoietic cell transplantation. Tissue Antigens 61:1-11. (Pubitemid 36286746)
25. Ringden O, T Ruutu, M Remberger, J Nikoskelainen, L Volin, L Vindelov, T Parkkali, S Lenhoff, B Sallerfors, et al. (1994). A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 83:2723-2730. (Pubitemid 24135867)
26. Ringden O, M Remberger, U Persson, P Ljungman, A Aldener, E Andstrom, J Aschan, P Bolme, G Dahllof, et al. (1995). Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 15:619-625.
27. Glucksberg H, R Storb, A Fefer, CD Buckner, PE Neiman, RA Clift, KG Lerner and ED Thomas. (1974). Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295-304.
28. Lee SJ, JP Klein, AJ Barrett, O Ringden, JH Antin, JY Cahn, MH Carabasi, RP Gale, S Giralt, et al. (2002). Severity of chronic graft-versus-host disease: association with treatment- related mortality and relapse. Blood 100:406-414. (Pubitemid 34761100)
29. Svahn BM, M Remberger, KE Myrback, K Holmberg, B Eriksson, P Hentschke, J Aschan, L Barkholt and O Ringden. (2002). Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 100:4317-4324. (Pubitemid 35429669)
30. Hazenberg MD, MC Verschuren, D Hamann, F Miedema and JJ vanDongen. (2001). T cell receptor excision circles asmarkers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 79:631-640. (Pubitemid 33071151)
31. Ye P and DE Kirschner. (2002). Measuring emigration of human thymocytes by T-cell receptor excision circles. Crit Rev Immunol 22:483-497. (Pubitemid 36548956)
32. Mackall CL, JA Punt, P Morgan, AG Farr and RE Gress. (1998). Thymic function in young/old chimeras: substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. Eur J Immunol 28:1886-1893. (Pubitemid 28271705)
33. Brown JA, K Stevenson, HT Kim, C Cutler, K Ballen, S McDonough, C Reynolds, M Herrera, D Liney, et al. (2010). Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis. Blood 115:4111-4119.
34. Fallen PR, L McGreavey, JA Madrigal, M Potter, M Ethell, HG Prentice, A Guimaraes and PJ Travers. (2003). Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 32:1001-1014. (Pubitemid 37461536)
35. Weinberg K, BR Blazar, JE Wagner, E Agura, BJ Hill, M Smogorzewska, RA Koup, MR Betts, RH Collins and DC Douek. (2001). Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97:1458-1466. (Pubitemid 32183773)
36. Norlin AC, D Sairafi, J Mattsson, P Ljungman, O Ringden and M Remberger. (2008). Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival. Bone Marrow Transplant 41:267-273. (Pubitemid 351260381)
37. Brown JA and VA Boussiotis. (2008). Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitution. Clin Immunol 127:286-297.
38. Gonzalo-Daganzo R, C Regidor, T Martin-Donaire, MA Rico, G Bautista, I Krsnik, R Fores, E Ojeda, I Sanjuan, et al. (2009). Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 11:278-288.
39. MacMillan ML, BR Blazer, TE DeFor and JE Wagner. (2009). Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant 43:447-454.
40. Escalon MP and KV Komanduri. (2010). Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution. Curr Opin Oncol 22:122-129.
41. Mackall CL, TA Fleisher, MR Brown, MP Andrich, CC Chen, IM Feuerstein, ME Horowitz, IT Magrath, AT Shad, et al. (1995). Age, thymopoiesis, and Cd4 + T-lymphocyte regeneration after intensive chemotherapy.NEngl JMed 332:143-149.
42. Rocha V, G Sanz and E Gluckman. (2004). Umbilical cord blood transplantation. Curr Opin Hematol 11:375-385. (Pubitemid 39491430)
43. Paulin T, O Ringden and B Lonnqvist. (1985). Faster immunological recovery after bone marrow transplantation in patients without cytomegalovirus infection. Transplantation 39:377-384. (Pubitemid 15107836)
44. Krampera M, S Sartoris, F Liotta, A Pasini, R Angeli, L Cosmi, A Andreini, F Mosna, B Bonetti, et al. (2007). Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells Dev 16:797-810. (Pubitemid 350125228)
45. Itoi M, N Tsukamoto, H Yoshida and T Amagai. (2007). Mesenchymal cells are required for functional development of thymic epithelial cells. Int Immunol 19:953-964. (Pubitemid 47386921)
46. Hazenberg MD, MCM Verschuren, D Hamann, F Miedema and JJM van Dongen. (2001). T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 79:631-640. (Pubitemid 33071151)
47. Ramirez PA, C Brunstein, B Miller, TEDeFor and DJWeisdorf. (2009). Delayed platelet recovery after allogeneic peripheral blood, marrow and umbilical cord stem cell transplantation: risk factors and clinical outcomes. Blood 114:357-357.
48. Bernardo ME, LM Ball, AM Cometa, H Roelofs, M Zecca, MA Avanzini, A Bertaina, L Vinti, A Lankester, et al. (2011). Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant 46:200-207.